Bear Sterns Pharmaceutical Industry Conference
Executive Summary
Merck VP-Government Affairs Teel Oliver and Senate Aging Committee staffer David Schulke will provide legislative update at third annual event will take place Sept. 26 at Vista International Hotel in New York City. Keynote speaker Istvan Bihari, Chinoin Pharmaceutical and Chemical Works, will talk about the changes experienced by pharmaceutical companies in the Eastern Bloc. Smith-Kline Beecham CEO Robert Bauman and Rhone-Poulenc Rorer CEO Robert Cawthorn will discuss the advantages of company consolidation.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.